Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 2
2006 4
2007 1
2008 2
2009 5
2010 1
2011 2
2012 3
2014 13
2015 5
2016 10
2017 15
2018 4
2019 13
2020 14
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Results by year
Filters applied: . Clear all
Page 1
Genetics of Obesity.
Kleinendorst L, van Haelst MM, van den Akker ELT. Kleinendorst L, et al. Among authors: van den akker elt. Exp Suppl. 2019;111:419-441. doi: 10.1007/978-3-030-25905-1_19. Exp Suppl. 2019. PMID: 31588542 Review.
Genetic obesity: next-generation sequencing results of 1230 patients with obesity.
Kleinendorst L, Massink MPG, Cooiman MI, Savas M, van der Baan-Slootweg OH, Roelants RJ, Janssen ICM, Meijers-Heijboer HJ, Knoers NVAM, Ploos van Amstel HK, van Rossum EFC, van den Akker ELT, van Haaften G, van der Zwaag B, van Haelst MM. Kleinendorst L, et al. Among authors: van den akker elt. J Med Genet. 2018 Sep;55(9):578-586. doi: 10.1136/jmedgenet-2018-105315. Epub 2018 Jul 3. J Med Genet. 2018. PMID: 29970488
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
Clément K, van den Akker E, Argente J, Bahm A, Chung WK, Connors H, De Waele K, Farooqi IS, Gonneau-Lejeune J, Gordon G, Kohlsdorf K, Poitou C, Puder L, Swain J, Stewart M, Yuan G, Wabitsch M, Kühnen P; Setmelanotide POMC and LEPR Phase 3 Trial Investigators. Clément K, et al. Among authors: van den akker e. Lancet Diabetes Endocrinol. 2020 Dec;8(12):960-970. doi: 10.1016/S2213-8587(20)30364-8. Epub 2020 Oct 30. Lancet Diabetes Endocrinol. 2020. PMID: 33137293 Clinical Trial.
Identifying underlying medical causes of pediatric obesity: Results of a systematic diagnostic approach in a pediatric obesity center.
Kleinendorst L, Abawi O, van der Voorn B, Jongejan MHTM, Brandsma AE, Visser JA, van Rossum EFC, van der Zwaag B, Alders M, Boon EMJ, van Haelst MM, van den Akker ELT. Kleinendorst L, et al. Among authors: van den akker elt. PLoS One. 2020 May 8;15(5):e0232990. doi: 10.1371/journal.pone.0232990. eCollection 2020. PLoS One. 2020. PMID: 32384097 Free PMC article.
Hair cortisol and inhaled corticosteroid use in asthmatic children.
Baan EJ, van den Akker ELT, Engelkes M, de Rijke YB, de Jongste JC, Sturkenboom MCJM, Verhamme KM, Janssens HM. Baan EJ, et al. Among authors: van den akker elt. Pediatr Pulmonol. 2020 Feb;55(2):316-321. doi: 10.1002/ppul.24551. Epub 2019 Oct 25. Pediatr Pulmonol. 2020. PMID: 31651095 Free PMC article.
LC-MS/MS-based reference intervals for hair cortisol in healthy children.
de Kruijff I, Noppe G, Kieviet N, Choenni V, Lambregtse-van den Berg MP, Begijn DGA, Tromp E, Dorst K, van Rossum EFC, de Rijke YB, van den Akker ELT. de Kruijff I, et al. Among authors: van den akker elt. Psychoneuroendocrinology. 2020 Feb;112:104539. doi: 10.1016/j.psyneuen.2019.104539. Epub 2019 Dec 6. Psychoneuroendocrinology. 2020. PMID: 31841987
[Clinical guideline 'Turner syndrome'].
van den Akker EL, van Alfen AA, Sas T, Kerstens M, Cools M, Lambalk CB. van den Akker EL, et al. Ned Tijdschr Geneeskd. 2014;158:A7375. Ned Tijdschr Geneeskd. 2014. PMID: 24666534 Review. Dutch.
86 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page